Market Cap: $16.37B
AA
Ascendis Pharma A/S
ASND
NASDAQ (NASDAQ Global Select)USD
Market Cap: $16.37B
Analysts estimated ASND earnings of $1.41 per share this quarter (Q2). ASND's actual earnings were $0.72 per share.
ASND EPS surprise of 95.63%Analysts estimated ASND earnings of $0.21 per share this quarter (Q1). ASND's actual earnings were $-0.77 per share.
ASND EPS surprise of -126.95%Analysts estimated ASND earnings of $-0.05 per share this quarter (Q4). ASND's actual earnings were $-0.55 per share.
ASND EPS surprise of -1098.26%Analysts estimated ASND earnings of $-0.22 per share this quarter (Q3). ASND's actual earnings were $-1.00 per share.
ASND EPS surprise of -345.63%Analysts estimated ASND earnings of $-1.27 per share this quarter (Q2). ASND's actual earnings were $-0.64 per share.
ASND EPS surprise of 49.75%Analysts estimated ASND earnings of $-0.98 per share this quarter (Q4). ASND's actual earnings were $-0.64 per share.
ASND EPS surprise of 34.50%Analysts estimated ASND earnings of $-1.44 per share this quarter (Q2). ASND's actual earnings were $-1.91 per share.
ASND EPS surprise of -32.32%Analysts estimated ASND earnings of $-1.53 per share this quarter (Q1). ASND's actual earnings were $-2.30 per share.
ASND EPS surprise of -50.09%Analysts estimated ASND earnings of $-2.07 per share this quarter (Q4). ASND's actual earnings were $-1.54 per share.
ASND EPS surprise of -25.51%